Actualités Helix Biomedix Inc (PK) - HXBM | Actions OTCMarkets

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CORRECTING and REPLACING Helix BioMedix Reports 2010 Financial Results

Please replace the release with the following corrected version due to multiple revisions. The corrected release reads:...

Helix BioMedix Reports 2010 Financial Results

Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the year ended...

Helix BioMedix Shares to Be Quoted On OTCQB

Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced that its common stock will be quoted...

Helix BioMedix Peptides Featured in American Academy of Dermatology Annual Meeting Research Posters Addressing Cellulite, Ros...

Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that its peptide technologies were featured...

Helix BioMedix Chief Scientific Officer Stepping Down, Company Focuses on Commercialization of Peptide Pipeline

Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that Dr. Timothy Falla will leave his post...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

Helix BioMedix Promotes Robin L. Carmichael to Vice President and Chief Operating Officer

Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that it has promoted Robin L. Carmichael to...

Helix BioMedix Adds $2.9 Million to Balance Sheet Following $11.0 Million Corporate Debt Retirement

Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that it received an aggregate of...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM 8-K ______________...

- Small Company Offering and Sale of Securities Without Registration (D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM D OMB APPROVAL OMB Number: 3235-0076 Expires: June 30, 2012...

- Small Company Offering and Sale of Securities Without Registration (D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM D OMB APPROVAL OMB Number: 3235-0076 Expires: June 30, 2012...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ FORM 8-K _______________...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

- Amended tender offer statement by Issuer (SC TO-I/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE TO (Rule 14d-100) (Amendment...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Helix Biomedix Inc (PK) (HXBM)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

HXBM Actualités

CORRECTING and REPLACING Helix BioMedix Reports 2010 Financial Results

Helix BioMedix Reports 2010 Financial Results

Helix BioMedix Shares to Be Quoted On OTCQB

Helix BioMedix Peptides Featured in American Academy of Dermatology Annual Meeting Research Posters Addressing Cellulite, Ros...

Helix BioMedix Chief Scientific Officer Stepping Down, Company Focuses on Commercialization of Peptide Pipeline

- Current report filing (8-K)

Helix BioMedix Promotes Robin L. Carmichael to Vice President and Chief Operating Officer

Helix BioMedix Adds $2.9 Million to Balance Sheet Following $11.0 Million Corporate Debt Retirement

- Current report filing (8-K)

- Small Company Offering and Sale of Securities Without Registration (D)

- Small Company Offering and Sale of Securities Without Registration (D)

- Current report filing (8-K)

- Current report filing (8-K)

- Amended tender offer statement by Issuer (SC TO-I/A)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Helix Biomedix Inc (PK) (HXBM) Actualités

Helix Biomedix Inc (PK) (HXBM)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

HXBM Actualités

CORRECTING and REPLACING Helix BioMedix Reports 2010 Financial Results

Helix BioMedix Reports 2010 Financial Results

Helix BioMedix Shares to Be Quoted On OTCQB

Helix BioMedix Peptides Featured in American Academy of Dermatology Annual Meeting Research Posters Addressing Cellulite, Ros...

Helix BioMedix Chief Scientific Officer Stepping Down, Company Focuses on Commercialization of Peptide Pipeline

- Current report filing (8-K)

Helix BioMedix Promotes Robin L. Carmichael to Vice President and Chief Operating Officer

Helix BioMedix Adds $2.9 Million to Balance Sheet Following $11.0 Million Corporate Debt Retirement

- Current report filing (8-K)

- Small Company Offering and Sale of Securities Without Registration (D)

- Small Company Offering and Sale of Securities Without Registration (D)

- Current report filing (8-K)

- Current report filing (8-K)

- Amended tender offer statement by Issuer (SC TO-I/A)

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application